CT011 Autologous CAR-T Cells

CT011 CAR-T cell therapy · CARsgen Therapeutics Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for CT011 Autologous CAR-T Cells, covering 2024-08-19 to 2024-08-19. Get the full timeline:

Most recent: Clinical Trial Update: CT011 Autologous CAR-T Cells in Patients With Hepatocellular Carcinoma at Risk of Recurrence After Surgical Resection [Phase 1]

See pricing